Clinical Trial

A Clinical Study Evaluating H1710 for Injection in Participants With Advanced Solid Tumors

Name: A Clinical Study Evaluating H1710 for Injection in Participants With Advanced Solid Tumors — clinical trial record (NCT06992713)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is a phase Ia clinical study evaluating H1710 for Injection in Participants with advanced solid tumors.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2025-05-19; most recent amendment 2026-06-16.

Status change: Not Yet Recruiting → Recruiting 2025-07-18

Trial Details

NCT Number	NCT06992713
Lead Sponsor	Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Conditions	Advanced Solid Tumor
Enrollment	36 participants
Start Date	2025-06-18
Primary Completion	2026-09-04 (estimated)
Study Completion	2026-11-30 (estimated)
Updated on ClinicalTrials.gov	2026-06-18